STOCK TITAN

Trump Media sets November 9 for Q3 2026 results

TMTG’s third-quarter results are scheduled to precede its November 9 call; the merger registration statement remains subject to effectiveness and approvals.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
425

Rhea-AI Filing Summary

Trump Media & Technology Group Corp. (DJT) and TAE Technologies, Inc. filed a second amended Form S-4 registration statement for their proposed merger. The registration statement has not yet become effective and includes TMTG’s proxy statement and prospectus, and TAE’s consent solicitation statement. The merger remains subject to required shareholder, stockholder or regulatory approvals and other closing conditions.

TMTG said it will issue third-quarter 2026 results after market close on November 9, 2026, before a 5:00 p.m. ET call about the quarter ended September 30, 2026. Interim CEO Kevin McGurn and CFO Phillip Juhan will host the call and answer previously submitted questions.

Third-quarter results call 5:00 p.m. ET on November 9, 2026 TMTG said results would be issued after market close before the call.
Question submission deadline 4:30 p.m. ET on November 9, 2026 Questions may be emailed for management consideration.
Audio replay available until December 9, 2026 Audio replay of the webcast.
Registration Statement regulatory
"the Registration Statement has not yet become effective"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
closing conditions regulatory
"satisfy other closing conditions"
Closing conditions are specific requirements or steps that must be met before a financial deal or transaction can be finalized. They act like a checklist that ensures all necessary details are confirmed and agreed upon, giving both parties confidence that the deal is ready to be completed. Meeting these conditions is essential for the transaction to move forward smoothly and successfully.
boron neutron capture therapy medical
"biologically-targeted boron neutron capture therapy"
A targeted radiation cancer therapy that uses a drug containing the isotope boron-10 to concentrate in tumor cells and then exposes the patient to a beam of low-energy neutrons; when boron-10 captures a neutron it undergoes a nuclear reaction that emits high-energy, very short-range particles (alpha particles and lithium nuclei) that destroy the nearby cancer cells while sparing surrounding tissue. Effectiveness depends on achieving a high concentration of boron in tumor cells relative to normal cells and access to a suitable neutron source (historically a reactor, increasingly accelerator-based systems).
microsecond-scale power control technical
"applies fusion-derived, microsecond-scale power control"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will DJT report third-quarter 2026 results and hold its call?

TMTG said it will issue results after market close on November 9, 2026, before a 5:00 p.m. ET call. The call will discuss the quarter ended September 30, 2026, and will be hosted by Interim CEO Kevin McGurn and CFO Phillip Juhan.

What is the status of the DJT and TAE merger registration statement?

TMTG and TAE filed a second amended Form S-4 registration statement for their proposed merger, but it has not yet become effective. The proposed transaction remains subject to required shareholder, stockholder or regulatory approvals and other closing conditions.

How can I submit a question for DJT’s earnings call?

Participants may email a question for management consideration to earnings@tmtgcorp.com before 4:30 p.m. ET on November 9, 2026. The call hosts will answer previously submitted questions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Filed by Trump Media & Technology Group Corp.

Pursuant to Rule 425 under the Securities Act of 1933 

and deemed filed pursuant to Rule 14a-12 

under the Securities Exchange Act of 1934 

Subject Company: Trump Media & Technology Group Corp.

Commission File No.: 001-40779 

Date: November 3, 2026

 

Trump Media & Technology Group and TAE Technologies File Amended Form S-4 Registration Statement for Proposed Merger

 

~TMTG to Release Third Quarter 2026 Results and Host Call on Monday, November 9, 2026~

 

SARASOTA, Fla. and Houston, November 3, 2026 – Trump Media & Technology Group Corp. (“TMTG”) (Nasdaq, NYSE Texas: DJT) and TAE Technologies, Inc. (“TAE”), an innovator in advanced technology across fusion energy, power management and cancer therapy, announced the filing of a second amended registration statement on Form S-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") in connection with the companies' previously announced merger. This filing marks continued progress towards merger completion.

 

TMTG Third Quarter 2026 Earnings Call

 

In addition, TMTG announced today that it will host a conference call at 5:00 p.m. ET on Monday, November 9, 2026, to discuss its financial results for the quarter ended September 30, 2026. Financial results will be issued in a press release after market close, prior to the call.

 

Interim CEO Kevin McGurn and CFO Phillip Juhan will host the call and answer previously-submitted questions. Participants may submit a question for management consideration by emailing it to earnings@tmtgcorp.com prior to 4:30 p.m. ET on Monday, November 9, 2026.

 

Access to the live webcast and replay of the conference call will be available here and on TMTG’s Investor Relations website at https://ir.tmtgcorp.com/. Additionally, you may listen to the live webcast via Truth+ at https://truthplus.tv/ or on your preferred device via the Truth+ app. The dial-in number for the conference call is 877-524-8416 (toll-free) or +1 412-902-1028 (international). Attendees are encouraged to dial in 15 minutes prior to the start of the call.

 

An audio replay of the webcast will be available until Wednesday, December 9, 2026. Dial 877-660-6853 (toll-free) or 201-612-7415 (international) to listen.

 

About Trump Media & Technology Group Corp.

 

The mission of Trump Media is to end Big Tech's assault on free speech by opening up the Internet and giving people their voices back. Trump Media operates Truth Social, a social media platform established as a safe harbor for free expression amid increasingly harsh censorship by Big Tech corporations; Truth+, a TV streaming platform focusing on family friendly live TV channels and on-demand content; and Truth.Fi, a financial services and FinTech brand incorporating America First investment vehicles.

 

About TAE Technologies, Inc.

 

Founded in 1998, TAE Technologies' mission is to develop and commercialize advanced technologies that solve the world's most difficult scientific and engineering challenges. TAE's north star is to deliver reliable, abundant, and clean fusion technology as a cost-competitive component of the future global energy supply. Fusion development serves as a forcing function, requiring TAE to develop technologies across a broad and deep spectrum of highly technical fields, with various commercial applications, including power solutions and life sciences. TAE's Power Solutions ("TPS") business unit applies fusion-derived, microsecond-scale power control to the challenges created by highly dynamic AI compute loads, through its flagship offering, TAE PowerFabric™. TAE's Life Sciences ("TLS") business unit set out to leverage TAE Technologies' proprietary fusion-derived particle accelerator technology to achieve a step change in radiation therapy, improve the lives of patients and combat difficult-to-treat cancers using biologically-targeted boron neutron capture therapy ("BNCT"). For more information, visit tae.com.

 

Forward-Looking Statements

 

This press release contains "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the proposed Merger between TMTG and TAE, the anticipated timing and benefits of the transaction, TMTG's and TAE's future business plans, and TAE's development and commercialization of fusion energy technology, including the Da Vinci prototype power plant. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others: the risk that the Merger may not be completed on the anticipated timeline or at all, including as a result of a failure to obtain required shareholder, stockholder or regulatory approvals or satisfy other closing conditions; the possibility that anticipated benefits of the Merger may not be realized; the significant capital required to develop and commercialize TAE's fusion technology; the risk that TAE may be unable to successfully develop or commercialize a viable fusion reactor on its expected timeline or at all; and other risks and uncertainties described in TMTG's filings with the SEC, including the Registration Statement and the risk factors described therein. TMTG and TAE undertake no obligation to update any forward-looking statements, except as required by law.

 

Important Information for Shareholders and Where to Find It

 

In connection with the proposed Merger, TMTG has filed the Registration Statement with the SEC, which includes a document that serves as a proxy statement of TMTG, a prospectus of TMTG and a consent solicitation statement of TAE (the "proxy statement/prospectus/consent solicitation statement"). The Registration Statement has not yet become effective. This press release is not a substitute for the Registration Statement, the definitive proxy statement/prospectus/consent solicitation statement or any other document that TMTG may file with the SEC in connection with the proposed Merger. INVESTORS AND SECURITY HOLDERS OF TMTG AND TAE ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS/CONSENT SOLICITATION STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT TMTG, TAE, THE PROPOSED MERGER AND RELATED MATTERS. Shareholders will be able to obtain, free of charge, copies of the Registration Statement and, once available, the definitive proxy statement/prospectus/consent solicitation statement and other documents filed with the SEC by TMTG through the website maintained by the SEC at www.sec.gov, or from TMTG's investor relations website at ir.tmtgcorp.com.

 

Participants in the Solicitation

 

TMTG, TAE and their respective executive officers, directors, other members of management and employees may be deemed, under SEC rules, to be participants in the solicitation of proxies from TMTG's shareholders with respect to the proposed transaction. Information regarding the respective executive officers and directors of TMTG and TAE is set forth in the Registration Statement and the proxy statement/prospectus/consent solicitation statement contained therein initially filed with the SEC on September 30, 2026, as amended. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the effective Registration Statement and other relevant materials to be filed with the SEC regarding the proposed transaction when they become available.

 

No Offer or Solicitation

 

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed Merger and is not a substitute for the proxy statement/prospectus/consent solicitation statement or any other document that TMTG may file with the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

Investor Relations Contact

 

Shannon Devine (MZ Group | Partner, MZ North America)

 

Email: shannon.devine@mzgroup.us

 

Media Contact

 

press@tmtgcorp.com

 


 

Keep reading